Protective Epitope Discovery and Design of MUC1-based Vaccine for Effective Tumor Protections in Immunotolerant Mice-Reference-Cited by-同舟云学术

Protective Epitope Discovery and Design of MUC1-based Vaccine for Effective Tumor Protections in Immunotolerant Mice

Published:2018-11-06 Issue:48 Volume:140 Page:16596-16609
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Wu Xuanjun,Yin Zhaojun,McKay Craig¹,Pett Christian²³,Yu Jin²,Schorlemer Manuel²,Gohl Trevor⁴,Sungsuwan Suttipun,Ramadan Sherif⁵,Baniel Claire,Allmon Anthony,Das Rupali⁴,Westerlind Ulrika²³,Finn M. G.¹^ORCID,Huang Xuefei^ORCID

Affiliation:

1. School of Chemistry & Biochemistry and School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia 30332, United States

2. Leibniz-Institut für Analytische Wissenschaften−ISAS−e.V., 44227 Dortmund, Germany

3. Department of Chemistry, Umeå University, 901 87 Umeå, Sweden

4. Department of Physiology, Michigan State University, East Lansing, Michigan 48824, United States

5. Chemistry Department, Faculty of Science, Benha University, Benha, Qaliobiya 13518, Egypt

Funder

National Cancer Institute

Bundesministerium f?r Bildung und Forschung

Deutsche Forschungsgemeinschaft

Verband der Chemischen Industrie

Ministerium f?r Kultur und Wissenschaft des Landes Nordrhein-Westfalen

Michigan State University Foundation

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/jacs.8b08473

Reference71 articles.

1. The promise of cancer vaccines

2. Therapeutic vaccines for cancer: an overview of clinical trials

3. The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

4. Natural Autoantibody to MUC1 Is a Prognostic Indicator for Non–Small Cell Lung Cancer

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protocol to prepare MUC1 glycopeptide vaccines and evaluate immunization effects in mice;STAR Protocols;2024-06

2. Inducing Long Lasting B Cell and T Cell Immunity Against Multiple Variants of SARS‐CoV‐2 Through Mutant Bacteriophage Qβ—Receptor Binding Domain Conjugate;Advanced Healthcare Materials;2024-05-17

3. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD;Journal of Translational Medicine;2024-03-27

4. Supramolecular complex glycoconjugate vaccine generates self-enhancement effects for carbohydrate antigen delivery;Chinese Chemical Letters;2024-02

5. Glycan-costumed virus-like particles promote type 1 anti-tumor immunity;2024-01-18